Intuitive Surgical (GB:0R29)

LSE:0R29

0R29

Intuitive Surgical

RESEARCH TOOLSreports

Intuitive Surgical (0R29) Share Forecast & Price Target

9 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

0R29 Analyst Ratings

Moderate Buy

14 Buy

5 Hold

0 Sell

Based on 19 analysts giving stock ratings to

Intuitive

Surgical

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

0R29 Stock 12 Month Forecast

Average Price Target

$622.73

▲(34.02% Upside)

Based on 19 Wall Street analysts offering 12 month price targets for Intuitive Surgical in the last 3 months. The average price target is $622.73 with a high forecast of $750.00 and a low forecast of $480.00. The average price target represents a 34.02% change from the last price of $464.64.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"438":"$438","751":"$751","516.25":"$516.3","594.5":"$594.5","672.75":"$672.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":750,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$750.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":622.73,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$622.73</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":480,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$480.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[438,516.25,594.5,672.75,751],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2025","6":"Oct<br/>2025","9":"Jan<br/>2026","12":"Apr<br/>2026","25":"Apr<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,466.13,487.9661538461538,509.8023076923077,531.6384615384616,553.4746153846154,575.3107692307692,597.146923076923,618.9830769230769,640.8192307692308,662.6553846153846,684.4915384615384,706.3276923076924,728.1638461538462,{"y":750,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,466.13,478.17615384615385,490.2223076923077,502.26846153846157,514.3146153846154,526.3607692307693,538.406923076923,550.4530769230769,562.4992307692307,574.5453846153846,586.5915384615384,598.6376923076923,610.6838461538462,{"y":622.73,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,466.13,467.1969230769231,468.26384615384615,469.33076923076925,470.3976923076923,471.4646153846154,472.53153846153845,473.59846153846155,474.6653846153846,475.7323076923077,476.79923076923075,477.86615384615385,478.9330769230769,{"y":480,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":494.63,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":518.29,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":550.28,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":534.74,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":479.729,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":471.865,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":439.5,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":532.999,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":570.02,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":571.304,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":497.89,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":497,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 42,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":466.13,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$750.00

Average Price Target$622.73

Lowest Price Target$480.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

David Roman

Goldman Sachs

$714→$609

Buy

31.07%

Upside

Assigned

04/09/26

Goldman Sachs Keeps Their Buy Rating on Intuitive Surgical (ISRG)

Joanne Wuensch

Citi

$590

Buy

26.98%

Upside

Reiterated

04/07/26

Analysts Offer Insights on Healthcare Companies: Humana (NYSE: HUM), Cigna (NYSE: CI) and Intuitive Surgical (NASDAQ: ISRG)

Vijay Kumar

Evercore ISI

$550→$480

Hold

3.31%

Upside

Reiterated

04/06/26

Intuitive Surgical price target lowered to $480 from $550 at Evercore ISIIntuitive Surgical price target lowered to $480 from $550 at Evercore ISI

Brandon Vazquez

William Blair

―

Buy

―

Reiterated

03/19/26

Intuitive Surgical: Stapler Reload Recall Seen as Contained, Buy Rating Reaffirmed

Nico Chen

DBS

$480

Hold

3.31%

Upside

Reiterated

03/18/26

Intuitive Surgical (ISRG) Gets a Hold from DBS

Travis Steed

Bank of America Securities

―

Buy

―

Reiterated

03/18/26

Analysts Offer Insights on Healthcare Companies: Healthequity (NASDAQ: HQY) and Intuitive Surgical (NASDAQ: ISRG)

Danielle Antalffy

UBS

$570→$550

Hold

18.37%

Upside

Assigned

03/17/26

Intuitive Surgical price target lowered to $550 from $570 at UBSIntuitive Surgical price target lowered to $550 from $570 at UBS

Shagun Singh Chadha

RBC Capital

$650

Buy

39.89%

Upside

Reiterated

02/24/26

RBC Capital Sticks to Its Buy Rating for Intuitive Surgical (ISRG)

Ryan Zimmerman

BTIG

$616

Buy

32.58%

Upside

Reiterated

02/18/26

BTIG Keeps Their Buy Rating on Intuitive Surgical (ISRG)

Mathew Blackman

TD Cowen

$660

Buy

42.05%

Upside

Reiterated

02/09/26

Analysts Offer Insights on Healthcare Companies: Roche Holding (Other OTC: RHHBY) and Intuitive Surgical (NASDAQ: ISRG)

Adam Maeder

Piper Sandler

$620

Buy

33.44%

Upside

Reiterated

02/02/26

Analysts Offer Insights on Healthcare Companies: AbbVie (NYSE: ABBV), Intuitive Surgical (NASDAQ: ISRG) and Thermo Fisher (NYSE: TMO)

Patrick Wood

Morgan Stanley

$650

Buy

39.89%

Upside

Reiterated

01/28/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Bristol-Myers Squibb (NYSE: BMY), HCA Healthcare (NYSE: HCA) and Intuitive Surgical (NASDAQ: ISRG)

Suraj Kalia

Oppenheimer

―

Hold

―

Reiterated

01/23/26

Analysts Conflicted on These Healthcare Names: Intuitive Surgical (NASDAQ: ISRG) and Abbott Laboratories (NYSE: ABT)

Richard Newitter

Truist Financial

$650

Buy

39.89%

Upside

Reiterated

01/23/26

Intuitive Surgical (ISRG) Gets a Buy from Truist Financial

Anthony Petrone

Mizuho Securities

―

Hold

―

Reiterated

01/23/26

Analysts Offer Insights on Healthcare Companies: COMPASS Pathways (NASDAQ: CMPS), Intuitive Surgical (NASDAQ: ISRG) and Sanofi (Other OTC: SNYNF)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

David Roman

Goldman Sachs

$714→$609

Buy

31.07%

Upside

Assigned

04/09/26

Goldman Sachs Keeps Their Buy Rating on Intuitive Surgical (ISRG)

Joanne Wuensch

Citi

$590

Buy

26.98%

Upside

Reiterated

04/07/26

Analysts Offer Insights on Healthcare Companies: Humana (NYSE: HUM), Cigna (NYSE: CI) and Intuitive Surgical (NASDAQ: ISRG)

Vijay Kumar

Evercore ISI

$550→$480

Hold

3.31%

Upside

Reiterated

04/06/26

Intuitive Surgical price target lowered to $480 from $550 at Evercore ISIIntuitive Surgical price target lowered to $480 from $550 at Evercore ISI

Brandon Vazquez

William Blair

―

Buy

―

Reiterated

03/19/26

Intuitive Surgical: Stapler Reload Recall Seen as Contained, Buy Rating Reaffirmed

Nico Chen

DBS

$480

Hold

3.31%

Upside

Reiterated

03/18/26

Intuitive Surgical (ISRG) Gets a Hold from DBS

Travis Steed

Bank of America Securities

―

Buy

―

Reiterated

03/18/26

Analysts Offer Insights on Healthcare Companies: Healthequity (NASDAQ: HQY) and Intuitive Surgical (NASDAQ: ISRG)

Danielle Antalffy

UBS

$570→$550

Hold

18.37%

Upside

Assigned

03/17/26

Intuitive Surgical price target lowered to $550 from $570 at UBSIntuitive Surgical price target lowered to $550 from $570 at UBS

Shagun Singh Chadha

RBC Capital

$650

Buy

39.89%

Upside

Reiterated

02/24/26

RBC Capital Sticks to Its Buy Rating for Intuitive Surgical (ISRG)

Ryan Zimmerman

BTIG

$616

Buy

32.58%

Upside

Reiterated

02/18/26

BTIG Keeps Their Buy Rating on Intuitive Surgical (ISRG)

Mathew Blackman

TD Cowen

$660

Buy

42.05%

Upside

Reiterated

02/09/26

Analysts Offer Insights on Healthcare Companies: Roche Holding (Other OTC: RHHBY) and Intuitive Surgical (NASDAQ: ISRG)

Adam Maeder

Piper Sandler

$620

Buy

33.44%

Upside

Reiterated

02/02/26

Analysts Offer Insights on Healthcare Companies: AbbVie (NYSE: ABBV), Intuitive Surgical (NASDAQ: ISRG) and Thermo Fisher (NYSE: TMO)

Patrick Wood

Morgan Stanley

$650

Buy

39.89%

Upside

Reiterated

01/28/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Bristol-Myers Squibb (NYSE: BMY), HCA Healthcare (NYSE: HCA) and Intuitive Surgical (NASDAQ: ISRG)

Suraj Kalia

Oppenheimer

―

Hold

―

Reiterated

01/23/26

Analysts Conflicted on These Healthcare Names: Intuitive Surgical (NASDAQ: ISRG) and Abbott Laboratories (NYSE: ABT)

Richard Newitter

Truist Financial

$650

Buy

39.89%

Upside

Reiterated

01/23/26

Intuitive Surgical (ISRG) Gets a Buy from Truist Financial

Anthony Petrone

Mizuho Securities

―

Hold

―

Reiterated

01/23/26

Analysts Offer Insights on Healthcare Companies: COMPASS Pathways (NASDAQ: CMPS), Intuitive Surgical (NASDAQ: ISRG) and Sanofi (Other OTC: SNYNF)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Intuitive Surgical

3 Months

xxx

Success Rate

22/29 ratings generated profit

Average Return

+7.82%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 75.86% of your transactions generating a profit, with an average return of +7.82% per trade.

1 Year

Joanne WuenschCiti

Success Rate

19/23 ratings generated profit

Average Return

+25.18%

reiterated a buy rating 3 days ago

Copying Joanne Wuensch's trades and holding each position for 1 Year would result in 82.61% of your transactions generating a profit, with an average return of +25.18% per trade.

2 Years

xxx

Success Rate

21/23 ratings generated profit

Average Return

+46.85%

reiterated a xxx

rating 3 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 91.30% of your transactions generating a profit, with an average return of +46.85% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0R29 Analyst Recommendation Trends

Rating

Dec 25

Jan 26

Feb 26

Mar 26

Apr 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0R29 has received 17 Buy Ratings, 9 Hold Ratings, and 0 Sell Ratings. 0R29 average Analyst price target in the past 3 months is 622.73.

Each month's total comprises the sum of three months' worth of ratings.

0R29 Financial Forecast

0R29 Earnings Forecast

Next quarter’s earnings estimate for 0R29 is $2.12 with a range of $2.03 to $2.35. The previous quarter’s EPS was $2.53. 0R29 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 0R29 has Performed in-line its overall industry.

0R29 Sales Forecast

Next quarter’s sales forecast for 0R29 is $2.62B with a range of $2.56B to $2.71B. The previous quarter’s sales results were $2.87B. 0R29 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 0R29 has Performed in-line its overall industry.

0R29 Stock Forecast FAQ

What is GB:0R29’s average 12-month price target, according to analysts?

Based on analyst ratings, Intuitive Surgical’s 12-month average price target is 622.73.

What is GB:0R29’s upside potential, based on the analysts’ average price target?

Intuitive Surgical has 34.02% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Intuitive Surgical a Buy, Sell or Hold?

Intuitive Surgical has a consensus rating of Moderate Buy, which is based on 14 buy ratings, 5 hold ratings and 0 sell ratings.

What is Intuitive Surgical’s share price target?

The average share price target for Intuitive Surgical is 622.73. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $750.00 ,and the lowest forecast is $480.00. The average share price target represents 34.02% Increase from the current price of $464.64.

What do analysts say about Intuitive Surgical?

Intuitive Surgical’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 19 Wall Streets Analysts.

How can I buy shares of Intuitive Surgical?

To buy shares of GB:0R29, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Intuitive Surgical (0R29) Share Forecast & Price Target

0R29 Analyst Ratings

0R29 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Intuitive Surgical

0R29 Analyst Recommendation Trends

0R29 Financial Forecast

0R29 Earnings Forecast

0R29 Sales Forecast

0R29 Stock Forecast FAQ

Detailed List of Analyst Forecasts